The involvement of brain structures in the adjuvant effect of muramyl dipeptide
- PMID: 2998564
- DOI: 10.1016/0361-9230(85)90033-4
The involvement of brain structures in the adjuvant effect of muramyl dipeptide
Abstract
With the aid of small electrolytic lesions we have studied the possible participation of brainstem structures in the adjuvant activity of muramyl dipeptide (MDP). The results suggest the involvement of the serotonergic groups B6.7.8 and serotonergic pathways in the upper region of the reticular formation. Since lesions in the caudal parts of reticular formation in the area of aminergic groups A1.3.5.7 with the participation of corresponding pathways also influenced the adjuvant effect of MDP the possible role of noradrenaline is also implicated.
Similar articles
-
Morphological and pharmacological evidence for the existence of brain regulatory circuits in the immune response.Int J Immunopharmacol. 1997 Sep-Oct;19(9-10):507-10. doi: 10.1016/s0192-0561(97)00049-0. Int J Immunopharmacol. 1997. PMID: 9637346
-
Serotonergic aspects of the response of human platelets to immune-adjuvant muramyl dipeptide.J Neuroimmunol. 1992 Mar;37(1-2):149-60. doi: 10.1016/0165-5728(92)90166-i. J Neuroimmunol. 1992. PMID: 1532180
-
Biotransformation of drugs in rats treated with a synthetic muramyl dipeptide, N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP).Int J Immunopharmacol. 1983;5(2):151-5. doi: 10.1016/0192-0561(83)90007-3. Int J Immunopharmacol. 1983. PMID: 6874168
-
Activation of immune responses by muroctasin.Arzneimittelforschung. 1988 Jul;38(7A):976-7. Arzneimittelforschung. 1988. PMID: 3056427 Review.
-
The interaction of immunomodulatory muramyl dipeptide with peripheral 5-HT receptors: overview of the current state.Int J Immunopharmacol. 1999 Mar;21(3):227-32. doi: 10.1016/s0192-0561(98)00079-4. Int J Immunopharmacol. 1999. PMID: 10348372 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources